Dr. Amalia Azzariti received a degree in Pharmaceutical Chemistry and Technology from the University School of Pharmacy, Bari, Italy in 1992, and from 1996 to 2000, was a PhD student in Biochemistry at the University of Bari, Bari, Italy. At present, Dr. Amalia Azzariti serves as a Senior Researcher and Coordinator of the Laboratory of Experimental Pharmacology at IRCCS Istituto Tumori Giovanni Paolo II in Bari (Italy). Dr. Amalia Azzariti's research interests include cancer cells, apoptosis, cancer therapy, cancer diagnostics, gemcitabine/nabpaclitaxel in pancreatic cancer, cancer research, cancer biomarkers, cell cycle regulation, signal transduction, phosphorylation, and cell migration. Dr. Amalia Azzariti is a Member of the EORTC and PAMM.
Research Keywords & Expertise
Cancer Biology
Pharmacology
Resistance
Drug Combination
Cancer Biomarkers
Fingerprints
29%
Resistance
7%
Pharmacology
5%
Drug Combination
Short Biography
Dr. Amalia Azzariti received a degree in Pharmaceutical Chemistry and Technology from the University School of Pharmacy, Bari, Italy in 1992, and from 1996 to 2000, was a PhD student in Biochemistry at the University of Bari, Bari, Italy. At present, Dr. Amalia Azzariti serves as a Senior Researcher and Coordinator of the Laboratory of Experimental Pharmacology at IRCCS Istituto Tumori Giovanni Paolo II in Bari (Italy). Dr. Amalia Azzariti's research interests include cancer cells, apoptosis, cancer therapy, cancer diagnostics, gemcitabine/nabpaclitaxel in pancreatic cancer, cancer research, cancer biomarkers, cell cycle regulation, signal transduction, phosphorylation, and cell migration. Dr. Amalia Azzariti is a Member of the EORTC and PAMM.